In particular, hepatic insulin resistance is manifested by the blunted ability of insulin to activate its receptor kinase and its downstream targets, resulting in incomplete suppression of hepatic glucose production and therefore a clear hyperglycaemia. The gene discussed is INS; the disease is Insulin resistance.